Vertex, Inc. (VERX) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ETCompany ParticipantsJoe Crivelli – Vice President of ...
Amdocs and Google Cloud Announce Partnership Expansion to Optimize 5G Network Operations with AI
Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, and Google Cloud today announced a major initiative to transform how telecommunications ...
Vertex price target lowered to $55 from $62 at DA Davidson
DA Davidson analyst William Jellison lowered the firm’s price target on Vertex (VERX) to $55 from $62 and keeps a Buy rating on the shares.
Vertex, OneStream and Workiva see bullish views at Goldman despite impact on stock
Goldman Sachs said it reiterated Buy ratings on OneStream ( NASDAQ: OS ), Vertex ( NASDAQ: VERX) and Workiva ( NYSE: WK) ...
FierceBiotech2d
Vertex axes Verve gene editing pact amid shift in R&D priorities
Vertex has backed out of its in vivo gene editing collaboration with Verve Therapeuti | Vertex has backed out of its in vivo ...
Vertex Announces Fourth Quarter and Full Year 2024 Financial Results
KING OF PRUSSIA, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results ...
Vertex Pharmaceuticals Inc. stock rises Friday, still underperforms market
The stock's rise snapped a four-day losing streak.
AFP1d
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective ...